Direct inhibition of ERK1/2 by VTX-11e leads to increased induction of apoptosis in a subset of pancreatic cancer cell lines as compared to MEK1/2 inhibition by selumetinib (AZD6244)

被引：3
|
作者：
Miermont, Anne M. [1 ]
Pflicke, Holger [1 ]
Guan, Hannah [1 ]
Chinnasamy, Harshini [1 ]
Thomas, Craig [2 ]
Rudloff, Udo [1 ]
机构：
[1] NCI, CCR, Bethesda, MD USA
[2] NCATS, Rockville, MD USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5538
引用
收藏
页数：1
相关论文
共 36 条
  • [1] Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244
    Ammoun, Sylwia
    Ristic, Natalia
    Matthies, Cordula
    Hilton, David A.
    Hanemann, C. Oliver
    NEUROBIOLOGY OF DISEASE, 2010, 37 (01) : 141 - 146
  • [2] Induction of COX-2 by feline calicivirus via activation of the MEK1-ERK1/2 pathway, and attenuation of feline lung inflammation and injury by MEK1 inhibitor AZD6244 (selumetinib)
    Liu, Ying
    Shi, Wen-da
    Xie, Qian-Qian
    Wang, Ji-Gui
    Gu, Chen-Chen
    Ji, Zhi-Hui
    Xiao, Jun
    Liu, Wei-Quan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 604 : 8 - 13
  • [3] Inhibition of ERK1/2 activity by the MEK1/2 inhibitor AZD6244 (ARRY-142886) induces human multiple myeloma cell apoptosis in the bone marrow microenvironment: A new therapeutic strategy for MM.
    Tai, Yu-Tzu
    Li, Xian-Feng
    Breitkreutz, Iris
    Song, Weihua
    Burger, Peter
    Rumizen, Matthew
    Hideshima, Teru
    Podar, Klaus
    Ghobrial, Irene
    Schlossman, Robert
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (11) : 987A - 987A
  • [4] MicroRNA expression patterns as potential biomarkers of responsiveness to the MEK1/2 inhibitor, AZD6244, in colorectal cancer cell lines
    Spreafico, Anna
    Tan, Aik Choon
    Tentler, John J.
    Nallapareddy, Sujatha
    Pitts, Todd M.
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [5] Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K-ras-Mutated Colorectal Cancer
    Tentler, John J.
    Nallapareddy, Sujatha
    Tan, Aik Choon
    Spreafico, Anna
    Pitts, Todd M.
    Morelli, M. Pia
    Selby, Heather M.
    Kachaeva, Maria I.
    Flanigan, Sara A.
    Kulikowski, Gillian N.
    Leong, Stephen
    Arcaroli, John J.
    Messersmith, Wells A.
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (12) : 3351 - 3362
  • [6] Combination therapy with inhibitors of mTOR and MEK1/2 (AZD6244) kinases, shows enhanced apoptosis and tumor growth inhibition in preclinical models
    Wilkinson, Robert
    Holt, Sarah
    Curtis, Nicola
    Logie, Armelle
    Sini, Patrizia
    Davies, Barry
    Chresta, Christine
    Guichard, Sylvie
    Smith, Paul
    CANCER RESEARCH, 2009, 69
  • [7] Evaluation of antiproliferative and apoptotic effects of the rational combination of the MEK1/2 inhibitor selumetinib (AZD6244) and inhibitors of the hedgehog pathway in colorectal cancer (CRC) cell lines.
    Spreafico, A.
    Tentler, J. J.
    Tan, A.
    Pitts, T. M.
    Kachaeva, M. I.
    Selby, H. M.
    Eckhardt, S. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [8] Targeted inhibition of the MEK-ERK signaling cascade by the selective MEK1/2 inhibitor AZD6244 (ARRAY-142886) for the treatment of hepatocellular carcinoma.
    Tran, Evelyne
    Soo, Khee Chee
    Chow, Pierce
    Huynh, Hung
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Members of the noncanonical WNT pathway confer resistance to the MEK 1/2 inhibitor AZD6244 in colorectal cancer cell lines
    Tentler, John J.
    Nallapareddy, Sujatha
    Tan, Aik Choon
    Spreafico, Anna
    Flanigan, Sara A.
    Pitts, Todd M.
    Eckhardt, S. Gail
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [10] MEK1/2 Inhibitor Selumetinib (AZD6244) Inhibits Growth of Ovarian Clear Cell Carcinoma in a PEA-15-Dependent Manner in a Mouse Xenograft Model
    Bartholomeusz, Chandra
    Oishi, Tetsuro
    Saso, Hitomi
    Akar, Ugur
    Liu, Ping
    Kondo, Kimie
    Kazansky, Anna
    Krishnamurthy, Savitri
    Lee, Jangsoon
    Esteva, Francisco J.
    Kigawa, Junzo
    Ueno, Naoto T.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 360 - 369
1234